Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer

Oncolytic peptides represent a novel, promising cancer treatment strategy with activity in a broad spectrum of cancer entities, including colorectal cancer (CRC). Cancer cells are killed by immunogenic cell death, causing long-lasting anticancer immune responses, a feature of particular interest in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleten, Karianne Giller, Eksteen, J. Johannes, Mauseth, Brynjar, Camilio, Ketil André, Vasskog, Terje, Sveinbjørnsson, Baldur, Rekdal, Øystein, Mælandsmo, Gunhild M., Flatmark, Kjersti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991660/
https://www.ncbi.nlm.nih.gov/pubmed/33762676
http://dx.doi.org/10.1038/s41598-021-86239-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991660/
https://www.ncbi.nlm.nih.gov/pubmed/33762676
http://dx.doi.org/10.1038/s41598-021-86239-6

Ejemplares similares